NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









JNPMEDI Partners

JNPMEDI Partners

Incheonen.jnpmedipartners.com

Overview

JNPMEDI Partners is a South Korean investment firm and global accelerator that specializes in the pharmaceutical, biotechnology, and medical device sectors by providing direct investment, investor matching, and comprehensive business development solutions.

Year Founded

2025

Portfolio Companies

1

Investments

JNPMEDI Partners investments
CompanyDateStageLead
DDH Co., Ltd.Apr 2026Series BCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersIncheon
Year Founded2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.